hUC-MSC-Exos Nasal Spray for autism spectrum disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Sep 2025: Trial started, NCT07243561
  2. 24 Nov 2025: Trial registered, NCT07243561

The trials

NCT07243561: Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism

State
Under way
Phase
Phase 1 and Phase 2
People
60 planned
Started
1 Sep 2025
Primary completion
30 Oct 2026
Arms
hUC-MSC-EXOs Nasal Spray Group
Results
None posted
  1. 1 Sep 2025: Trial started
  2. 24 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.